{
  "num_tested_probands": [
    [
      1
    ],
    [
      1
    ],
    [
      1
    ],
    [
      0
    ]
  ],
  "num_positive_het_probands": [
    [
      0
    ],
    [
      0
    ],
    [
      0
    ],
    [
      0
    ]
  ],
  "positive_phenotypes": [
    [
      "infantile-onset, Levodopa-responsive Parkinsonism"
    ],
    [
      "Infantile-onset leukoencephalopathy",
      "Infantile-onset Parkinsonism"
    ],
    [
      "Levodopa-responsive Parkinsonism",
      "Infantile-onset Leukoencephalopathy"
    ],
    []
  ],
  "num_compound_or_double_hets": [
    [
      0
    ],
    [
      2
    ],
    [
      1
    ],
    [
      0
    ]
  ],
  "explanation": {
    "num_tested_probands": [
      [
        "The patient is the only proband tested in this report."
      ],
      [
        "The patient was the only proband tested."
      ],
      [
        "The patient is the only proband tested in this report."
      ],
      [
        "No probands were tested in the provided articles."
      ]
    ],
    "num_positive_het_probands": [
      [
        "No proband was found to be heterozygous for a pathogenic variant."
      ],
      [
        "No proband was heterozygous for a pathogenic variant."
      ],
      [
        "No heterozygous probands were reported to have pathogenic variants."
      ],
      [
        "No heterozygous probands were identified in the provided articles."
      ]
    ],
    "positive_phenotypes": [
      [
        "The patient presents with infantile-onset, Levodopa-responsive Parkinsonism, which is a clinical hallmark of Parkinson's disease."
      ],
      [
        "The patient had infantile-onset leukoencephalopathy and infantile-onset Parkinsonism."
      ],
      [
        "The patient has infantile-onset Levodopa-responsive Parkinsonism and a clinical presentation of infantile-onset Leukoencephalopathy."
      ],
      [
        "None"
      ]
    ],
    "num_compound_or_double_hets": [
      [
        "There are no compound or double heterozygotes reported in this case."
      ],
      [
        "The patient was compound heterozygous for two variants in the WARS2 gene."
      ],
      [
        "One compound heterozygous mutation in WARS2 was reported."
      ],
      [
        "No compound or double heterozygotes were reported in the provided articles."
      ]
    ]
  },
  "quote_snippets": [
    [
      "compound heterozygous mutations in WARS2 (p.Trp13Gly, p.Ser228Trp)",
      "infantile-onset, Levodopa-responsive Parkinsonism at the age of 2 years",
      "decreased steady-state WARS2 protein and normal OXPHOS content"
    ],
    [
      "mutations in AARS2 in a series of CSF1R-negative patients with adult-onset leu-koencephalopathy with axonal spheroids and pigmented glia.",
      "The patient was evaluated at the NIH at age 9 and had advanced Levodopa-responsive Parkinsonism with prominent and unpredictable \u201con-off\u201d fluctuations, peak-dose dyskinesia, stooped posture and disabling off-dystonia."
    ],
    [
      "The first family carried one of the alleles found in our patient (p.Trp13Gly), along with a frameshift mutation predicted to result in loss of function; the latter may account for the more severe intellectual disability seen in the affected siblings.",
      "This difference likely reflects the unique impact that a specific variant in WARS2 can have on the resulting cellular and clinical phenotype, or different methodologies.",
      "The association of the patient\u2019s WARS2 variants to Parkinsonism or PD may be further clarified by systematically interrogating available cohorts for such mutations."
    ],
    [
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      "",
      ""
    ]
  ]
}